𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review

✍ Scribed by Carolin M. Grimminger; Peter V. Danenberg


Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
434 KB
Volume
268
Category
Article
ISSN
0302-9530

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Prognostic significance of human papillo
✍ Ahmad R. Sedaghat; Zhe Zhang; Shahnaz Begum; Robert Palermo; Simon Best; Karen M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

## Abstract ## Objectives/Hypothesis: The human papillomavirus (HPV) has been identified as a causative factor in 20% to 25% of all head and neck squamous cell carcinomas (HNSCC). Ongoing research suggests that the presence of HPV DNA in HNSCC predicts a positive prognosis with respect to disease‐

HPV16 semiquantitative viral load and se
✍ Aimée R. Kreimer; Gary M. Clifford; Peter J.F. Snijders; Xavier Castellsagué; Ch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 77 KB

## Abstract A considerable subset of oropharyngeal squamous cell carcinomas (SCCs) are positive for human papillomavirus (HPV); however, delineating etiologically‐associated HPV infections from SCCs with concurrent HPV infection unrelated to tumorigenesis is challenging. Viral load assessment in bi

Prognostic significance of biomarkers in
✍ Hemangini H. Vora; Neelam G. Shah; Devendra D. Patel; Trupti I. Trivedi; Priya R 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

## Abstract ## Background and Objectives Expression of a panel of biomarkers, such as p53, Bcl‐2, Cyclin D1, c‐__myc__, p21ras, c‐erb B2, cytokeratin‐19 (CK‐19), and factor VIII–related antigen (FVIII‐RA), was studied together in anterior tongue tumors from the oral cavity and in posterior tongue

Prognostic factors in oral cavity and or
✍ Benjamin Marcus; Douglas Arenberg; Julia Lee; Celina Kleer; Douglas B. Chepeha; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

## Abstract ## BACKGROUND The survival of patients with head and neck squamous cell carcinoma (HNSCC) remains unaffected despite recent therapeutic advances. To reverse this trend, reliable and clinically applicable markers of tumor aggressiveness must be identified. One such marker may be the tum